Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor.
Xu Z, Liu Y, Song B, Ren B, Xu X, Lin R, Zhu X, Chen C, Yang S, Zhu Y, Jiang W, Li W, Xia Y, Hu L, Chen S, Chan CC, Li J, Zhang X, Yang L, Tian X, Ding CZ.
Xu Z, et al. Among authors: chan cc.
Bioorg Med Chem Lett. 2024 Apr 24;107:129769. doi: 10.1016/j.bmcl.2024.129769. Online ahead of print.
Bioorg Med Chem Lett. 2024.
PMID: 38670537